Latham & Watkins has successfully represented Boston Scientific Corp. in its acquisition of Silk Road Medical Inc. for a total of $1.16 billion. Meanwhile, Wilson Sonsini Goodrich & Rosati provided legal guidance to Silk Road Medical.
This transaction is part of an increasing trend in the Boston market, where legal activities have notably surged, particularly within the healthcare and clean energy sectors. The Boston corporate department of Latham & Watkins, led by Julie Scallen alongside New York partner Ian Nussbaum, spearheaded the legal work for Boston Scientific. Scallen has previously guided the company in acquisitions of similar magnitude, including Apama Medical Inc. and Symetis SA.
Additionally, Fried Frank lawyers Philip Richter and Roy Tannenbaum advised BofA Securities, Silk Road Medical’s financial adviser, maintaining the strategic alignment of the transaction.
For a deeper dive into the legal implications and further details of this transaction, visit the full article here.